(19)

(11)

EP 3 625 212 A2

(12)

(88) Date of publication A3: 12.12.2019 (43) Date of publication: 25.03.2020 Bulletin 2020/13 (21) Application number: 18801735.4 (22) Date of filing: 18.05.2018

(51) International Patent Classification (IPC):  C07D 207/09(2006.01) C07C 317/36(2006.01) (86) International application number: PCT/US2018/033552 (87) International publication number: WO 2018/213813 (22.11.2018 Gazette 2018/47)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 18.05.2017 US 201762508263 P (71) Applicant: LB Pharmaceuticals Inc. New York, New York 10022 (US)	(72) Inventors: VAINO, Andrew, R. New York, NY 10022 (US) GRATTAN, Vincent, T. New York, NY 10022 (US) PRENSKY, Zachary New York, NY 10022 (US) (74) Representative: Bond, Christopher William  Forresters IP LLP Skygarden Erika-Mann-Strasse 11 80636 München 80636 München (DE)